Ito R, Statland B E, Sher G, Knutzen V
Adv Exp Med Biol. 1983;156:205-23.
Analytical assays that measure the amidolytic activity of plasma kallikrein (PK) must overcome the problem of anti-kallikrein inhibition during the activation of PPK to PK. We resolved this problem by exposure of plasma to 50 mg/L dextran sulfate in acetone/water (35/65, vol/vol) at 0 degrees C for 15 minutes. PK activity was assayed using the chromogenic substrate, S-2302 (KABI). A centrifugal analyzer (CentrifiChem) was used to monitor the change in absorbance at 405 nm and 37 degrees C. The assay was linear to a value 3 times that found in normal human plasma. The specificity of the substrate for PK was demonstrated by using plasma deficient in PPK (Fletcher trait) diluted with normal human pooled plasma (NHPP). Day-to-day analytical variation was 2.4% for NHPP having a mean value of 85.9 mukat/L (n = 26). Using our amidolytic method, we determined PPK values in 50 healthy adults, 80 pregnant women during each trimester of gestation, and 151 neonates (cord blood specimens). The middle 95% reference interval for the adults was 54.0 - 118.8 mukat/L, for pregnant women at first trimester: 59.0 - 129.0, second trimester: 72.3 - 161.5, third trimester: 75.6 - 152.4, day of labor: 67.7 - 144.9, and 1-9 weeks postpartum: 69.4 - 151.0 mukat/L, and for the neonate: 11.5 - 44.9 mukat/L. We observed that women on oral contraceptives had significantly greater PPK values than those not on oral contraceptives. Intra-individual variation of PPK values was relatively low in non-pregnant women with the day-to-day coefficient of variation being 4.1 - 6.1% in 5 subjects monitored over a 30 day period. The high value of inter-individual/intra-individual ratio was appreciated in pregnant women in that the PPK value observed during the first trimester was a means to predict the value approaching term. The mean PPK value during the first trimester was 105.1% of the mean seen in non-pregnant women while the mean PPK value nearing term was 130.1% of that value.
测量血浆激肽释放酶(PK)酰胺水解活性的分析测定法必须克服在将前激肽释放酶(PPK)激活为PK的过程中抗激肽释放酶抑制的问题。我们通过将血浆在0℃下暴露于丙酮/水(35/65,体积/体积)中50mg/L的硫酸葡聚糖15分钟来解决这个问题。使用发色底物S-2302(卡比)测定PK活性。使用离心分析仪(CentrifiChem)监测在405nm和37℃下吸光度的变化。该测定法在正常人类血浆中测得值的3倍范围内呈线性。通过用正常人类混合血浆(NHPP)稀释缺乏PPK的血浆(弗莱彻性状)来证明底物对PK的特异性。对于平均值为85.9mukat/L的NHPP,日常分析变异为2.4%(n = 26)。使用我们的酰胺水解方法,我们测定了50名健康成年人、80名妊娠各期孕妇以及151名新生儿(脐血标本)的PPK值。成年人的中间95%参考区间为54.0 - 118.8mukat/L,妊娠早期孕妇为:59.0 - 129.0,妊娠中期为:72.3 - 161.5,妊娠晚期为:75.6 - 152.4,分娩日为:67.7 - 144.9,产后1 - 9周为:69.4 - 151.0mukat/L,新生儿为:11.5 - 44.9mukat/L。我们观察到服用口服避孕药的女性的PPK值显著高于未服用口服避孕药的女性。在非孕妇中,PPK值的个体内变异相对较低,在30天内监测的5名受试者中,日常变异系数为4.1 - 6.1%。在孕妇中观察到个体间/个体内比值较高,因为妊娠早期观察到的PPK值是预测接近足月时值的一种手段。妊娠早期的平均PPK值是非孕妇平均值的105.1%,而接近足月时的平均PPK值是该值的130.1%。